Kobiolabs, Inc.

Hyun Ju You

Gwang Pyo Ko

June Chul Lee

Tae-Wook Nam

Woo Ri Ko

So Yon Yoon

Seok Cheon Song

Giljae Lee

Won Keun Kim

Tae Wook Nam

Bo Mi Kwon

Bo-Ram Cho

Hyo Shin Yoon

Chung Hwan Cho

The present invention relates toSNUG-61027 strain (accession number KCTC 13530BP) and use thereof, specifically, a composition for suppressing appetite or preventing, ameliorating, alleviating or treating metabolic diseases, comprising the strain, or a culture solution thereof, etc. or a B2UM07 protein isolated therefrom as an active ingredient, and use thereof for suppressing appetite or preventing, ameliorating, alleviating or treating metabolic diseases, and a method of suppressing appetite or preventing, ameliorating, alleviating or treating metabolic diseases using the same are provided. Through this, among the anti-obesity effects, not only weight reduction and glucose homeostasis regulation, but also the effect on brown fat and the effect of secreting appetite regulating hormones are exhibited.

strain and use thereof

The present invention relates to a composition for preventing, alleviating or treating liver injury, for example, nonalcoholic fatty liver, and more specifically, it relates to a composition for preventing or treating liver injury comprising aspp. strain.

Composition and method for preventing, alleviating, or treating liver injury

The present invention relates to a novelsp. isolation strain having an activity to inhibit the growth of vaginitis pathogens, and a pharmaceutical composition, a health functional food, and a cleansing product, comprising the strain as an active ingredient. Therefore, the present invention exhibits an effect of inhibiting the growth ofspp. pathogens associated with the infection with human papillomavirus (HPV) and the incidence of bacterial vaginitis,as a vaginitis pathogen, andas a causative yeast of, and an effect of recovering and maintaining the vaginal microflora, and thus can be used for the prevention and treatment of female vaginitis.

sp. strain having ability to inhibit growth of vaginal pathogenic microorganisms

A strain ofKBL693 and the use thereof are disclosed. The strain ofKBL693 (Accession No. KCTC 13519BP) attenuates allergic reactions of cells, significantly improves symptoms of atopic dermatitis, and exhibits anti-inflammatory and anti-fungal effects. Thus, the single strain alone can achieve all the purposes of alleviating atopic dermatitis and other allergic diseases and improving inflammatory diseases and autoimmune diseases, thereby finding advantageous applications as a probiotic substance. In addition, the strain, based on the anti-fungal activity thereof, can be advantageously utilized in a skin external preparation against various skin diseases caused by fungi, and in a cosmetic composition and a functional patch for alleviating sensitive skin.

Lactobacillus crispatus KBL693 strain and use thereof

KBL693 strain and use thereof

Growing community of inventors

Incheon, South Korea

Hyun Ju You